☰

William H. Velander - Publications

Affiliations: 
Chemical and Biomolecular Engineering The University of Nebraska - Lincoln, Lincoln, NE 
Area:
Chemical Engineering, Biomedical Engineering
Website:
https://engineering.unl.edu/chme/william-h-velander/
Tree Info Similar researchers PubMed Report error

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fabian FM, Ismail AEA, Wang O, Lei Y, Velander WH. Reversible associations between human plasma fibronectin and fibrinogen γγ' heterodimer observed by high pressure size exclusion chromatography and dynamic light scattering. Analytical Biochemistry. 113701. PMID 32268127 DOI: 10.1016/J.Ab.2020.113701  0.307
2019 Laguia-Becher M, Zaldúa Z, Xu W, Marconi PL, Velander W, Alvarez MA. Co-expressing Turnip Crinkle Virus-coat protein with the serine protease α-thrombin precursor (pFIIa) in Nicotiana benthamiana Domin In Vitro Cellular & Developmental Biology – Plant. 55: 88-98. DOI: 10.1007/S11627-018-09956-0  0.345
2018 Wang O, Ismail A, Fabian FM, Lin H, Li Q, Elowsky C, Carlson MA, Burgess W, Velander WH, Kidambi S, Lei Y. A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery. Journal of Biomedical Materials Research. Part A. PMID 30152030 DOI: 10.1002/Jbm.A.36508  0.339
2015 Zhao J, Xu W, Ross JW, Walters EM, Butler SP, Whyte JJ, Kelso L, Fatemi M, Vanderslice NC, Giroux K, Spate LD, Samuel MS, Murphy CN, Wells KD, Masiello NC, ... ... Velander WH, et al. Engineering protein processing of the mammary gland to produce abundant hemophilia B therapy in milk. Scientific Reports. 5: 14176. PMID 26387706 DOI: 10.1038/Srep14176  0.677
2015 Vanderslice NC, Messer AS, Vadivel K, Bajaj SP, Phillips M, Fatemi M, Xu W, Velander WH. Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography. Analytical Biochemistry. 479: 6-14. PMID 25804408 DOI: 10.1016/J.Ab.2015.03.019  0.663
2014 Carlson MA, Calcaterra J, Johanning JM, Pipinos II, Cordes CM, Velander WH. A totally recombinant human fibrin sealant. The Journal of Surgical Research. 187: 334-42. PMID 24169144 DOI: 10.1016/J.Jss.2013.09.039  0.645
2013 Calcaterra J, Van Cott KE, Butler SP, Gil GC, Germano M, van Veen HA, Nelson K, Forsberg EJ, Carlson MA, Velander WH. Recombinant human fibrinogen that produces thick fibrin fibers with increased wound adhesion and clot density. Biomacromolecules. 14: 169-78. PMID 23215461 DOI: 10.1021/Bm301579P  0.677
2012 Velander W. Transgenic blood proteins: An abundant source for next generation therapies with worldwide availability Journal of Bioequivalence & Bioavailability. DOI: 10.4172/0975-0851.S1.003  0.39
2011 Pipe SW, Miao H, Butler SP, Calcaterra J, Velander WH. Functional factor VIII made with von Willebrand factor at high levels in transgenic milk. Journal of Thrombosis and Haemostasis : Jth. 9: 2235-42. PMID 21920013 DOI: 10.1111/J.1538-7836.2011.04505.X  0.692
2011 Zhao J, Walters E, Calcaterra J, Ross J, Spate L, Samuel M, Rieke A, Murphy C, Butler S, Velander W, Prather R. 339 BIOENGINEERING OF THE MAMMARY GLAND OF LIVESTOCK: INCREASED PROPEPTIDE PROCESSING OF FACTOR IX IN THE MILK OF TRANSGENIC PIGS BY CO-EXPRESSION OF FURIN Reproduction, Fertility and Development. 23: 265. DOI: 10.1071/Rdv23N1Ab339  0.669
2011 Carlson M, Velander W, Pipinos I, Johanning J, Calcaterra J. A Totally Recombinant Factor XIII-Supplemented Fibrin Sealant Journal of Surgical Research. 165: 317. DOI: 10.1016/J.Jss.2010.11.326  0.663
2009 Gil GC, Velander WH, Van Cott KE. N-glycosylation microheterogeneity and site occupancy of an Asn-X-Cys sequon in plasma-derived and recombinant protein C. Proteomics. 9: 2555-67. PMID 19343721 DOI: 10.1002/Pmic.200800775  0.389
2008 Gil GC, Velander WH, Van Cott KE. Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk. Glycobiology. 18: 526-39. PMID 18456721 DOI: 10.1093/Glycob/Cwn035  0.337
2008 Brewster LP, Washington C, Brey EM, Gassman A, Subramanian A, Calceterra J, Wolf W, Hall CL, Velander WH, Burgess WH, Greisler HP. Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials. 29: 327-36. PMID 17950455 DOI: 10.1016/J.Biomaterials.2007.09.034  0.72
2007 Pipe S, Miao H, Butler S, Kaufman R, Calcaterra J, Velander W. EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS Journal of Thrombosis and Haemostasis. 5: O-T-013-O-T-013. DOI: 10.1111/J.1538-7836.2007.Tb01670.X  0.662
2004 Butler SP, O'Sickey TK, Lord ST, Lubon H, Gwazdauskas FC, Velander WH. Secretion of recombinant human fibrinogen by the murine mammary gland. Transgenic Research. 13: 437-50. PMID 15587268 DOI: 10.1007/S11248-004-9589-8  0.335
2004 Van Cott KE, Monahan PE, Nichols TC, Velander WH. Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide. Haemophilia : the Official Journal of the World Federation of Hemophilia. 10: 70-6. PMID 15479375 DOI: 10.1111/J.1365-2516.2004.00983.X  0.356
2004 Lindsay M, Gil GC, Cadiz A, Velander WH, Zhang C, Van Cott KE. Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations. Journal of Chromatography. A. 1026: 149-57. PMID 14763741 DOI: 10.1016/J.Chroma.2003.11.006  0.411
2001 Van Cott KE, Lubon H, Gwazdauskas FC, Knight J, Drohan WN, Velander WH. Recombinant human protein C expression in the milk of transgenic pigs and the effect on endogenous milk immunoglobulin and transferrin levels. Transgenic Research. 10: 43-51. PMID 11252382 DOI: 10.1023/A:1008963817646  0.386
1999 Van Cott KE, Butler SP, Russell CG, Subramanian A, Lubon H, Gwazdauskas FC, Knight J, Drohan WN, Velander WH. Transgenic pigs as bioreactors: a comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland. Genetic Analysis : Biomolecular Engineering. 15: 155-60. PMID 10596756 DOI: 10.1016/S1050-3862(99)00020-0  0.395
1999 Butler S, O'Sickey T, Lord S, Lubon H, Velander W, Gwazdauskas F. Production and secretion of recombinant human fibrinogen by the transgenic murine mammary gland Theriogenology. 51: 417. DOI: 10.1016/S0093-691X(99)91976-3  0.373
1998 Cott KEV, Velander WH. Transgenic animals as drug factories: a new source of recombinant protein therapeutics. Expert Opinion On Investigational Drugs. 7: 1683-1690. PMID 15991910 DOI: 10.1517/13543784.7.10.1683  0.346
1998 Degener A, Belew M, Velander WH. Zn2+-selective purification of recombinant proteins from the milk of transgenic animals Journal of Chromatography A. 799: 125-137. PMID 9550105 DOI: 10.1016/S0021-9673(97)01037-6  0.399
1997 Paleyanda RK, Velander WH, Lee TK, Scandella DH, Gwazdauskas FC, Knight JW, Hoyer LW, Drohan WN, Lubon H. Transgenic pigs produce functional human factor VIII in milk. Nature Biotechnology. 15: 971-5. PMID 9335047 DOI: 10.1038/Nbt1097-971  0.414
1997 Van Cott KE, Lubon H, Russell CG, Butler SP, Gwazdauskas FC, Knight J, Drohan WN, Velander WH. Phenotypic and genotypic stability of multiple lines of transgenic pigs expressing recombinant human protein C. Transgenic Research. 6: 203-12. PMID 9167268 DOI: 10.1023/A:1018442124584  0.367
1997 Morçöl T, Subramanian A, Velander WH. Dot-blot analysis of the degree of covalent modification of proteins and antibodies at amino groups Journal of Immunological Methods. 203: 45-53. PMID 9134029 DOI: 10.1016/S0022-1759(97)00013-6  0.582
1997 Butler SP, Cott KV, Subrumanian A, Gwazduaskas FC, Velander WH. Current progress in the production of recombinant human fibrinogen in the milk of transgenic animals Thrombosis and Haemostasis. 78: 537-542. DOI: 10.1055/S-0038-1657584  0.369
1996 Subramanian A, Velander WH. Effect of Antibody Orientation on Immunosorbent Performance Journal of Molecular Recognition. 9: 528-535. PMID 9174936 DOI: 10.1002/(Sici)1099-1352(199634/12)9:5/6<528::Aid-Jmr296>3.0.Co;2-Q  0.588
1996 Van Cott KE, Williams B, Velander WH, Gwazdauskas F, Lee T, Lubon H, Drohan WN. Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland Journal of Molecular Recognition. 9: 407-414. PMID 9174918 DOI: 10.1002/(Sici)1099-1352(199634/12)9:5/6<407::Aid-Jmr277>3.0.Co;2-X  0.424
1996 Lee TK, Bangalore N, Velander W, Drohan WN, Lubon H. Activation of recombinant human protein C. Thrombosis Research. 82: 225-234. PMID 8732626 DOI: 10.1016/0049-3848(96)00069-2  0.343
1996 Luboń H, Paleyanda RK, Velander WH, Drohan WN. Blood proteins from transgenic animal bioreactors Transfusion Medicine Reviews. 10: 131-143. PMID 8721970 DOI: 10.1016/S0887-7963(96)80089-7  0.385
1996 Subramanian A, Paleyanda RK, Lubon H, Williams BL, Gwazdauskas FC, Knight JW, Drohan WN, Velander WH. Rate limitations in posttranslational processing by the mammary gland of transgenic animals. Annals of the New York Academy of Sciences. 782: 87-96. PMID 8659928 DOI: 10.1111/J.1749-6632.1996.Tb40550.X  0.609
1995 Page RL, Butler SP, Subramanian A, Gwazdauskas FC, Johnson JL, Velander WH. Transgenesis in mice by cytoplasmic injection of polylysine/DNA mixtures. Transgenic Research. 4: 353-60. PMID 7581516 DOI: 10.1007/Bf01973753  0.533
1994 Morcöl T, Akers RM, Johnson JL, Williams BL, Gwazdauskas FC, Knight JW, Lubon H, Paleyanda RK, Drohan WN, Velander WH. The porcine mammary gland as a bioreactor for complex proteins. Annals of the New York Academy of Sciences. 721: 218-33. PMID 8010672 DOI: 10.1111/J.1749-6632.1994.Tb47394.X  0.37
1994 Drohan WN, Zhang DW, Paleyanda R, Chang R, Wroble M, Velander W, Lubon H. Inefficient processing of human protein C in the mouse mammary gland. Transgenic Research. 3: 355-364. PMID 8000432 DOI: 10.1007/Bf01976767  0.416
1994 Fodor WL, Williams BL, Matis LA, Madri JA, Rollins SA, Knight JW, Velander W, Squinto SP. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proceedings of the National Academy of Sciences of the United States of America. 91: 11153-7. PMID 7526391 DOI: 10.1073/Pnas.91.23.11153  0.314
1994 Subramanian A, Van Cott KE, Milbrath DS, Velander WH. Role of local antibody density effects on immunosorbent efficiency Journal of Chromatography A. 672: 11-24. DOI: 10.1016/0021-9673(94)80590-3  0.551
1992 Velander WH, Madurawe RD, Subramanian A, Kumar G, Sinai-Zingde G, Riffle JS, Orthner CL. Polyoxazoline-peptide adducts that retain antibody avidity. Biotechnology and Bioengineering. 39: 1024-30. PMID 18600901 DOI: 10.1002/Bit.260391006  0.536
1992 Velander WH, Subramanian A, Madurawe RD, Orthner CL. The use of Fab-masking antigens to enhance the activity of immobilized antibodies. Biotechnology and Bioengineering. 39: 1013-1023. PMID 18600900 DOI: 10.1002/Bit.260391005  0.577
1992 Velander WH, Johnson JL, Page RL, Russell CG, Subramanian A, Wilkins TD, Gwazdauskas FC, Pittius C, Drohan WN. High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proceedings of the National Academy of Sciences of the United States of America. 89: 12003-7. PMID 1465430 DOI: 10.1073/Pnas.89.24.12003  0.61
1992 Wilkins TD, Velander W. Isolation of recombinant proteins from milk Journal of Cellular Biochemistry. 49: 333-338. PMID 1429861 DOI: 10.1002/Jcb.240490403  0.354
1992 Velander WH, Page RL, Morcöl T, Russell CG, Canseco R, Young JM, Drohan WN, Gwazdauskas FC, Wilkins TD, Johnson JL. Production of biologically active human protein C in the milk of transgenic mice. Annals of the New York Academy of Sciences. 665: 391-403. PMID 1416618 DOI: 10.1111/J.1749-6632.1992.Tb42602.X  0.337
1991 Orthner CL, Highsmith FA, Tharakan J, Madurawe RD, Morcol T, Velander WH. Comparison of the performance of immunosorbents prepared by site-directed or random coupling of monoclonal antibodies Journal of Chromatography A. 558: 55-70. PMID 1744216 DOI: 10.1016/0021-9673(91)80111-S  0.352
1989 Velander WH, Orthner CL, Tharakan JP, Madurawe RD, Ralston AH, Strickland DK, Drohan WN. Process Implications for Metal-Dependent Immunoaffinity Interactions Biotechnology Progress. 5: 119-125. DOI: 10.1002/Btpr.5420050310  0.373
Show low-probability matches.